The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
Open Access
- 26 September 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 12 (1), 209
- https://doi.org/10.1186/1471-2474-12-209
Abstract
In the absence of head-to-head trials, indirect comparisons of randomized placebo-controlled trials may provide a viable option to assess relative efficacy. The purpose was to estimate the relative efficacy of reduction of fractures in post-menopausal women, and to assess robustness of the results.This publication has 56 references indexed in Scilit:
- The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-AnalysisSeminars in Arthritis and Rheumatism, 2011
- Placebo-Controlled Trials in Osteoporosis — Proceeding with CautionThe New England Journal of Medicine, 2010
- The Ethics of Placebo in Studies with Fracture End Points in OsteoporosisThe New England Journal of Medicine, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisThe New England Journal of Medicine, 2009
- Indirect comparisons of treatments based on systematic reviews of randomised controlled trialsInternational Journal of Clinical Practice, 2009
- The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisonsRheumatology, 2007
- Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trialClimacteric, 2005
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- A Bayesian Method for Synthesizing Evidence: The Confidence Profile MethodInternational Journal of Technology Assessment in Health Care, 1990